We are live on
!
Find out more
BCA
Benchmark Capital Advisors Portfolio holdings
AUM
$101M
1-Year Est. Return
0.8%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$127M
AUM Growth
+$153K
(+0.12%)
Cap. Flow
+$1.75M
Cap. Flow
% of AUM
1.38%
Top 10 Holdings %
Top 10 Hldgs %
30.97%
Holding
147
New
23
Increased
40
Reduced
44
Closed
7
Avg Time Held Equity + Options
9.5
quarters
Top 10 Avg Time Held Equity + Options
5.8
quarters
Top 20 Avg Time Held Equity + Options
7.5
quarters
Avg Time Held Equity only
9.5
quarters
Top 10 Avg Time Held Equity only
5.8
quarters
Top 20 Avg Time Held Equity only
7.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WisdomTree Japan Hedged Equity Fund
DXJ
|
+$1.96M |
| 2 |
Novartis
NVS
|
+$1.31M |
| 3 |
Cisco
CSCO
|
+$743K |
| 4 |
AbbVie
ABBV
|
+$729K |
| 5 |
Johnson Controls International
JCI
|
+$611K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVA
Covanta Holding Corporation
CVA
|
+$1.98M |
| 2 |
AERI
Aerie Pharmaceuticals
AERI
|
+$1.67M |
| 3 |
Apple
AAPL
|
+$1.07M |
| 4 |
Terex
TEX
|
+$870K |
| 5 |
Citigroup
C
|
+$718K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.14% |
| 2 | Healthcare | 16.68% |
| 3 | Real Estate | 16.39% |
| 4 | Technology | 12.22% |
| 5 | Financials | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TRIB
101
Trinity Biotech
TRIB
$5.12M
| $241K | 0.19% |
268
-2
| -0.7% | -$1.7K |
2013 Q2
16 quarters
|
|
102
DELISTED
Goldman Sachs Group Depositary Shares (1/1000 Interest of 6.2% Non-Cum. Prfrd. Stock, Series B) Call
GS.PRB.CL
| $241K | 0.19% |
9,200
| – | – |
2014 Q1
13 quarters
|
|
|
TOO
103
DELISTED
Teekay Offshore Partners L.P.
TOO
| $240K | 0.19% |
83,500
| – | – |
2015 Q4
6 quarters
|
|
104
FedEx
FDX
$68.8B
| $239K | 0.19% |
1,100
-200
| -15% | -$39.5K |
2016 Q3
3 quarters
|
|
105
iShares Preferred and Income Securities ETF
PFF
$12.1B
| $237K | 0.19% |
+6,050
| New | +$235K |
2017 Q2
0 quarters
|
|
106
State Street Health Care Select Sector SPDR ETF
XLV
$43.9B
| $236K | 0.19% |
2,975
-400
| -12% | -$30.5K |
2014 Q4
10 quarters
|
|
107
INNOVATE Corp
VATE
$87M
| $235K | 0.19% |
4,000
| – | – |
2016 Q3
3 quarters
|
|
108
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
| $222K | 0.18% |
+16,600
| New | +$222K |
2017 Q2
0 quarters
|
|
109
McDonald's
MCD
$167B
| $212K | 0.17% |
+1,384
| New | +$200K |
2017 Q2
0 quarters
|
|
110
Invesco Aerospace & Defense ETF
PPA
$7.45B
| $202K | 0.16% |
+4,400
| New | +$199K |
2017 Q2
0 quarters
|
|
111
Darling Ingredients
DAR
$9.96B
| $197K | 0.16% |
+12,500
| New | +$193K |
2017 Q2
0 quarters
|
|
112
Axogen
AXGN
$2.12B
| $193K | 0.15% |
11,500
| – | – |
2015 Q2
8 quarters
|
|
113
Rockwell Medical
RMTI
$31.6M
| $182K | 0.14% |
208
-5
| -2% | -$4.1K |
2015 Q4
6 quarters
|
|
114
Element Solutions
ESI
$9.07B
| $178K | 0.14% |
14,000
| – | – |
2015 Q4
6 quarters
|
|
115
abrdn Asia-Pacific Income Fund
FAX
$529M
| $167K | 0.13% |
5,583
+400
| +8% | +$12K |
2013 Q2
16 quarters
|
|
116
ProShares UltraShort S&P500
SDS
$347M
| $165K | 0.13% |
130
| – | – |
2015 Q3
7 quarters
|
|
117
Celldex Therapeutics
CLDX
$2.22B
| $160K | 0.13% |
4,320
| – | – |
2015 Q4
6 quarters
|
|
|
TWO
118
DELISTED
Two Harbors Investment
TWO
| $149K | 0.12% |
+1,875
| New | +$150K |
2017 Q2
0 quarters
|
|
119
BioLineRX
BLRX
$10.8M
| $122K | 0.1% |
240
| – | – |
2014 Q1
13 quarters
|
|
120
DELISTED
Real Industry, Inc.
RELY
| $119K | 0.09% |
41,000
-1,500
| -4% | -$4.09K |
2015 Q2
8 quarters
|
|
|
BNBX
121
DELISTED
BNB PLUS CORP
BNBX
| – | – |
0
| – | – |
2015 Q2
8 quarters
|
|
122
GoPro
GPRO
$244M
| $81K | 0.06% |
+10,000
| New | +$84.6K |
2017 Q2
0 quarters
|
|
|
CEMI
123
DELISTED
Chembio diagnostics, Inc.
CEMI
| $73K | 0.06% |
+12,000
| New | +$74.9K |
2017 Q2
0 quarters
|
|
124
Global Ship Lease
GSL
$1.63B
| $70K | 0.06% |
7,169
-2,806
| -28% | -$29.1K |
2014 Q4
10 quarters
|
|
|
PDL.B
125
DELISTED
PRESIDENTAL RLTY CL B
PDL.B
| $12K | 0.01% |
115,300
| – | – |
2013 Q2
16 quarters
|
|
Similar funds
OIMU
7A
JCP
DCM
BCEM
QAM
CFA
BPV
Benchmark Capital Advisors's Q2 2017 Portfolio in Review
As of Q2 2017, Benchmark Capital Advisors held 147 positions worth $127M, up 0.12% from $127M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Benchmark Capital Advisors's Q2 2017 filing shows 23 new, 40 increased, 44 reduced and 7 closed positions. Its largest new stake was WisdomTree Japan Hedged Equity Fund: 114,690 shares worth $1.99M. The largest sale was Covanta Holding Corporation, an estimated $1.98M.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Real Estate.
- Benchmark Capital Advisors's largest Q2 2017 buy was WisdomTree Japan Hedged Equity Fund: 114,690 shares worth $1.99M.
- Benchmark Capital Advisors added most to Devon Energy in Q2 2017, an estimated $530K increase.
- Benchmark Capital Advisors's biggest Q2 2017 reduction was Aerie Pharmaceuticals, cutting an estimated $1.67M.
- Benchmark Capital Advisors fully exited Covanta Holding Corporation in Q2 2017, selling an estimated $1.98M.
- Benchmark Capital Advisors's ten largest holdings make up 31% of its $127M portfolio in Q2 2017.
- Benchmark Capital Advisors opened 23 new positions and closed 7 in Q2 2017.
- Benchmark Capital Advisors's portfolio value rose 0.12% quarter-over-quarter to $127M.
Based on Benchmark Capital Advisors's 13F filing for Q2 2017, filed 9 Aug 2017.